(Angiotech Pharmaceuticals Inc., Vancouver) -- Angiotech Pharmaceuticals Inc., global specialty pharmaceutical and medical device company, recently announced the appointment of Victor Diaz as senior vice president, global manufacturing and supply chain management.
“With his significant accomplishments in manufacturing and supply chain operations in health care and the medical device industries, we are pleased to welcome Victor to Angiotech’s senior management team,” says Dr. William Hunter, president and CEO of Angiotech.Diaz has more than 20 years of experience in the health care, medical device and medical instruments industries. He brings to Angiotech a solid background in global manufacturing, Six Sigma, procurement, distribution, supply chain, lean manufacturing, inventory management, and ISO and FDA regulations and compliance.
“As we anticipate more growth in the future, we believe that Victor will lend his experience to align Angiotech’s people and manufacturing resources, build out our supply chain strategy, develop best practices across all of our facilities, and increase manufacturing and operational productivity,” adds Dr. Hunter.
Prior to joining Angiotech, Diaz was vice president of global operations at Teleflex Medical, the medical device and instrument manufacturing division of Teleflex Corp. During his career at Teleflex, Diaz led a staff of 4,200 people and was responsible for the global manufacturing, procurement, distribution and complete supply chain with 25 plants and 23 distribution centers in 10 countries in Europe, Asia, Latin America and the United States. Diaz also spent three years at Tyco Healthcare Respiratory, where he was vice president of manufacturing responsible for 11 manufacturing facilities in five countries.
Prior to joining Tyco Respiratory, Diaz was vice president of manufacturing for Kendall Healthcare, a subsidiary of Tyco Healthcare that manufactured disposable medical products, where he was responsible for 4,000 employees at FDA-compliant ISO- and EN-certified plants in Europe, Mexico, Venezuela, Malaysia, Thailand and the United States.
For more information, visit www.angiotech.com/news/press-releases/pdf/2007/03-07-2007_DiazAnnouncement_FINAL.pdf.
Add new comment